"HLA Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases.
Descriptor ID |
D006680
|
MeSH Number(s) |
D23.050.301.500.450 D23.050.705.552.450
|
Concept/Terms |
HLA Antigens- HLA Antigens
- Antigens, HLA
- HL-A Antigens
- Antigens, HL-A
- HL A Antigens
- Human Leukocyte Antigens
- Antigens, Human Leukocyte
- Leukocyte Antigens, Human
- Leukocyte Antigens
- Antigens, Leukocyte
|
Below are MeSH descriptors whose meaning is more general than "HLA Antigens".
Below are MeSH descriptors whose meaning is more specific than "HLA Antigens".
This graph shows the total number of publications written about "HLA Antigens" by people in this website by year, and whether "HLA Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 2 | 3 |
1996 | 4 | 0 | 4 |
1997 | 2 | 1 | 3 |
1998 | 2 | 2 | 4 |
1999 | 5 | 2 | 7 |
2000 | 3 | 0 | 3 |
2001 | 3 | 4 | 7 |
2002 | 6 | 2 | 8 |
2003 | 2 | 3 | 5 |
2004 | 2 | 1 | 3 |
2005 | 3 | 4 | 7 |
2006 | 3 | 3 | 6 |
2007 | 5 | 2 | 7 |
2008 | 3 | 3 | 6 |
2009 | 4 | 6 | 10 |
2010 | 7 | 6 | 13 |
2011 | 8 | 3 | 11 |
2012 | 6 | 14 | 20 |
2013 | 7 | 8 | 15 |
2014 | 8 | 3 | 11 |
2015 | 10 | 4 | 14 |
2016 | 5 | 8 | 13 |
2017 | 9 | 3 | 12 |
2018 | 6 | 6 | 12 |
2019 | 5 | 7 | 12 |
2020 | 3 | 7 | 10 |
2021 | 4 | 7 | 11 |
2022 | 0 | 3 | 3 |
2023 | 0 | 4 | 4 |
2024 | 3 | 9 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA Antigens" by people in Profiles.
-
Interplay between donor age and HLA-DP matching in 10/10?HLA-matched unrelated donor HCT. Blood Adv. 2024 10 22; 8(20):5438-5449.
-
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024 10 22; 8(20):5306-5314.
-
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplant Cell Ther. 2024 Dec; 30(12):1139-1154.
-
Insights into the genetic landscape of systemic sclerosis. Best Pract Res Clin Rheumatol. 2024 Dec; 38(4):101981.
-
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations. Transplant Cell Ther. 2024 Sep; 30(9):909.e1-909.e11.
-
Future directions in haploidentical hematopoietic stem cell transplantation. Hematology. 2024 Dec; 29(1):2366718.
-
SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection. Clin Lymphoma Myeloma Leuk. 2024 Dec; 24(12):821-826.
-
Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes. Blood Adv. 2024 05 14; 8(9):2235-2242.
-
Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis. Leukemia. 2024 Jun; 38(6):1432-1434.
-
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease. Bone Marrow Transplant. 2024 Jul; 59(7):918-927.